Un
nuovo studio, pubblicato sulla
rivista Nature (vedi estratto in inglese sotto), dimostra che
alcuni emulsionanti possono
contribuire in maniera significativa a contrarre obesità, diabete di tipo
2 e infiammazioni intestinali poiché interferiscono sull’equilibrio microbico
del tratto gastro-intestinale.
Gli emulsionanti
giudicati “pericolosi” sono i seguenti:
A destare preoccupazione sembrerebbe essere il ruolo importante di questi emulsionanti in elenco, nella sindrome metabolica, che comporta l’innalzamento di tutti i fattori di rischio cardiovascolare (obesità, ipertensione arteriosa e ipercolesterolemia) dovuta ad un’alterazione dell’equilibrio microbico intestinale che queste sostanze riescono ad apportare.
carbometilcellulosa
(CMC)
|
E
461-462-463-464-465-466
|
carragenina
|
E 407
|
pectina
|
E 440
|
gomma di
xantano
|
presente
in molti prodotti per celiaci) (E 415)
|
amidi
modificati
|
E1404 - E1410 -
E1412 - E1413 - E1414 - E1420 - E1422 - E1440 - E1450 - E1451 - E1452
|
maltodestrine
|
aumentano
la permeabilità intestinale e rischio m. Crohn
|
polisorbato-80
|
E 433
|
A destare preoccupazione sembrerebbe essere il ruolo importante di questi emulsionanti in elenco, nella sindrome metabolica, che comporta l’innalzamento di tutti i fattori di rischio cardiovascolare (obesità, ipertensione arteriosa e ipercolesterolemia) dovuta ad un’alterazione dell’equilibrio microbico intestinale che queste sostanze riescono ad apportare.
Estratto:
Dietary emulsifiers
impact the mouse gut microbiota promoting colitis and metabolic syndrome. The intestinal tract is inhabited by a
large and diverse community of microbes collectively referred to as the gut microbiota. While
the gut microbiota provides
important benefits to its host, especially in metabolism and immune
development, disturbance of the microbiota-host
relationship is associated with numerous chronic inflammatory diseases,
including inflammatory bowel disease and the group of obesity-associated
diseases collectively referred to as metabolic syndrome.
A primary means by which the intestine is protected from its microbiota is via multi-layered mucus structures that cover
the intestinal surface, thereby allowing the vast majority of gut bacteria
to be kept at a safe distance from epithelial cells that line the intestine.
Thus, agents that disrupt mucus-bacterial interactions might have the
potential to promote diseases associated with gut inflammation.
Consequently, it has been
hypothesized that emulsifiers,
detergent-like molecules that are a ubiquitous component of processed foods and
that can increase bacterial translocation across epithelia in vitro, might be promoting the increase in inflammatory bowel disease
observed since the mid-twentieth century.
Here we report that, in mice, relatively low concentrations of two
commonly used emulsifiers, namely carboxymethylcellulose and
polysorbate-80, induced low-grade inflammation and obesity / metabolic syndrome in wild-type hosts and promoted robust colitis in mice predisposed to this disorder.
Emulsifier-induced metabolic syndrome was associated with microbiota encroachment, altered species composition and
increased pro-inflammatory potential.
Use of germ-free mice and faecal transplants indicated that such changes
in microbiota were necessary and sufficient for both low-grade
inflammation and metabolic syndrome.
These results support the emerging concept that perturbed host-microbiota interactions resulting in low-grade inflammation
can promote adiposity and its associated metabolic effects.
Moreover, they suggest that the broad use of emulsifying agents might be
contributing to an increased societal incidence of obesity / metabolic syndrome and other chronic inflammatory diseases.
Altro articolo completo da leggere, sull'interazione tra Crohn e Maltodestrine.
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0052132
Altro articolo completo da leggere, sull'interazione tra Crohn e Maltodestrine.
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0052132
Nessun commento:
Posta un commento